We are live on ! Find out more
ETC

Exchange Traded Concepts Portfolio holdings

AUM $21.9B
1-Year Est. Return 68.6%
This Fund
S&P 500
This Quarter Est. Return
-4.98%
1 Year Est. Return
+68.6%
3 Year Est. Return
+158.93%
5 Year Est. Return
+186.62%
10 Year Est. Return
AUM
$4.98B
AUM Growth
-$179M
Cap. Flow
+$168M
Cap. Flow %
3.37%
Top 10 Hldgs %
45.09%
Holding
1,446
New
273
Increased
488
Reduced
411
Closed
251

Sector Composition

Rank Sector Weight
1 Technology 11.34%
2 Energy 7.89%
3 Healthcare 6.04%
4 Communication Services 6.02%
5 Consumer Discretionary 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STAA icon
201
STAAR Surgical
STAA
$1.13B
$2.31M 0.05%
28,895
-8,146
-22% -$607K
IQV icon
202
IQVIA
IQV
$40.3B
$2.31M 0.05%
9,981
-1,033
-9% -$245K
TWST icon
203
Twist Bioscience
TWST
$5.42B
$2.28M 0.05%
46,212
+28,584
+162% +$1.58M
CDNA icon
204
CareDx
CDNA
$1.84B
$2.28M 0.05%
61,627
-1,824
-3% -$71.1K
SYK icon
205
Stryker
SYK
$132B
$2.28M 0.05%
8,528
-1,360
-14% -$352K
CTLT
206
DELISTED
CATALENT, INC.
CTLT
$2.27M 0.05%
20,509
-24,850
-55% -$2.59M
CRL icon
207
Charles River Laboratories
CRL
$11.5B
$2.27M 0.05%
8,004
-3,099
-28% -$956K
BSX icon
208
Boston Scientific
BSX
$69.1B
$2.25M 0.05%
50,922
-21,880
-30% -$948K
AZTA icon
209
Azenta
AZTA
$1.34B
$2.21M 0.04%
26,728
-10,826
-29% -$929K
ALNY icon
210
Alnylam Pharmaceuticals
ALNY
$38.2B
$2.21M 0.04%
13,532
+4,618
+52% +$704K
AKYA
211
DELISTED
Akoya BioSciences
AKYA
$2.19M 0.04%
199,067
-8,398
-4% -$97.4K
CSII
212
DELISTED
Cardiovascular Systems, Inc.
CSII
$2.18M 0.04%
96,392
-80,127
-45% -$1.56M
SBNY
213
DELISTED
Signature Bank
SBNY
$2.18M 0.04%
7,414
-1,778
-19% -$578K
BFLY icon
214
Butterfly Network
BFLY
$1.86B
$2.17M 0.04%
456,207
-59,264
-11% -$325K
HCAT icon
215
Health Catalyst
HCAT
$157M
$2.17M 0.04%
83,034
+13,907
+20% +$395K
MASI
216
DELISTED
Masimo
MASI
$2.17M 0.04%
14,874
+4,202
+39% +$807K
VOO icon
217
Vanguard S&P 500 ETF
VOO
$972B
$2.16M 0.04%
+5,199
New +$2.13M
PSA icon
218
Public Storage
PSA
$62.3B
$2.16M 0.04%
5,527
+787
+17% +$286K
PEN icon
219
Penumbra
PEN
$12.6B
$2.13M 0.04%
9,585
-4,169
-30% -$926K
IART icon
220
Integra LifeSciences
IART
$1.55B
$2.12M 0.04%
32,940
-12,693
-28% -$836K
ALGN icon
221
Align Technology
ALGN
$12.5B
$2.03M 0.04%
4,656
+380
+9% +$185K
EXAS
222
DELISTED
Exact Sciences
EXAS
$2.02M 0.04%
28,943
-5,419
-16% -$396K
OLP
223
One Liberty Properties
OLP
$551M
$2.01M 0.04%
65,270
+8,808
+16% +$273K
BILI icon
224
Bilibili
BILI
$7.55B
$2M 0.04%
78,335
+38,382
+96% +$1.23M
SAFT icon
225
Safety Insurance
SAFT
$1.51B
$1.97M 0.04%
21,652
-1,726
-7% -$147K

Similar funds

Exchange Traded Concepts's Q1 2022 Portfolio in Review

As of Q1 2022, Exchange Traded Concepts held 1,446 positions worth $4.98B, down 3.5% from $5.16B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Exchange Traded Concepts deployed $168M of net new capital in Q1 2022, opening 273 new positions and adding to 488 existing holdings. Its largest new stake was Vanguard Long-Term Treasury ETF: 2,207,627 shares worth $177M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 13% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Vanguard Energy ETF, an estimated $182M trimmed.

  • Exchange Traded Concepts's largest Q1 2022 buy was Vanguard Long-Term Treasury ETF: 2,207,627 shares worth $177M.
  • Exchange Traded Concepts added most to Vanguard Utilities ETF in Q1 2022, an estimated $268M increase.
  • Exchange Traded Concepts's biggest Q1 2022 reduction was Vanguard Energy ETF, cutting an estimated $182M.
  • Exchange Traded Concepts fully exited Vanguard Mid-Cap ETF in Q1 2022, selling an estimated $155M.
  • Exchange Traded Concepts's ten largest holdings make up 45% of its $4.98B portfolio in Q1 2022.
  • Exchange Traded Concepts opened 273 new positions and closed 251 in Q1 2022.
  • Exchange Traded Concepts's portfolio value fell 3.5% quarter-over-quarter to $4.98B.

Based on Exchange Traded Concepts's 13F filing for Q1 2022, filed 26 Apr 2022.